1. "Melanoma Disease Management Team"
  2. "Surgery"
  3. "Michael Postow"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (12)
  3. Book Section (1)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (38)
  2. Melanoma Disease Management Team (38)
  3. Melanoma and Immunotherapeutics Service (38)
  4. Solid Tumor Oncology Division (38)
  5. Surgery (38)
  6. GSK Faculty (25)

More Groups

People
  1. Michael Postow (38)
  2. Charlotte Ariyan (22)
  3. Alexander Shoushtari (20)
  4. Daniel Coit (17)
  5. Jedd Wolchok (17)
  6. Margaret Callahan (16)

More People

Years
  1. 2022 (3)
  2. 2021 (5)
  3. 2020 (4)
  4. 2019 (2)
  5. 2018 (7)
  6. 2017 (6)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Surgical Oncology (6)
  3. Nature (2)
  4. Ophthalmology (2)
  5. Cancer (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Springer (7)
  3. Nature Publishing Group (6)
  4. Elsevier Science, Inc. (3)
  5. Wiley Blackwell (3)
  6. Elsevier Inc. (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Journal Article

    Amaria, R. N.; Postow, M.; Burton, E. M.; Tezlaff, M. T.; Ross, M. I.; Torres-Cabala, C.; Glitza, I. C.; Duan, F.; Milton, D. R.; Busam, K.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma
    Meeting Abstract

    Amaria, R. N.; Postow, M. A.; Tetzlaff, M. T.; Ross, M. I.; Glitza, I. C.; McQuade, J. L.; Wong, M. K. K.; Gershenwald, J. E.; Goepfert, R.; Keung, E. Z. Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
    Journal Article

    Andrews, M. C.; Duong, C. P. M.; Gopalakrishnan, V.; Iebba, V.; Chen, W. S.; Derosa, L.; Khan, M. A. W.; Cogdill, A. P.; White, M. G.; Wong, M. C.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save